Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis - A prospective two-year study in 273 patients

By Myklebust Geirmund   Gran Jan Tore  

Scandinavian Journal of Rheumatology, Vol. 30, Iss. 5, 2001-10 ,pp. : 260-267

Informa Healthcare

Access to resources Recommend Favorite

No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroids: A cross sectional study

By Haugeberg G.   Myklebust G.   Dovland H.   Mikkelsen B.   Gran J. T.  

Scandinavian Journal of Rheumatology, Vol. 29, Iss. 3, 2000-06 ,pp. : 163-169

Informa Healthcare

Access to resources Recommend Favorite

Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis

By Nordborg C.   Larsson K.   Åman P.   Nordborg E.  

Scandinavian Journal of Rheumatology, Vol. 38, Iss. 2, 2009-01 ,pp. : 144-148

Informa Healthcare

Access to resources Recommend Favorite

Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study

By Corrao Salvatore   Pistone Giovanni   Scaglione Rosario   Colomba Daniela   Calvo Luigi   Licata Giuseppe  

Clinical Rheumatology, Vol. 28, Iss. 1, 2009-01 ,pp. : 89-92

Springer Publishing Company

Access to resources Recommend Favorite

Myelodysplastic and Myeloproliferative Syndromes Associated with Giant Cell Arteritis and Polymyalgia Rheumatica: A Coincidental Coexistence or a Causal Relationship?

By Espinosa G.   Font J.   Muñoz-Rodríguez F. J.   Cervera R.   Ingelmo M.  

Clinical Rheumatology, Vol. 21, Iss. 4, 2002-08 ,pp. : 309-313

Springer Publishing Company

Access to resources Recommend Favorite